**5. Conclusions**

The proposed calculation method provides an estimation of delivered patient value using standard references. Such a dashboard could be used to implement VBHC in everyday clinical practice. Our results revealed that TSAs performed at our institution provided substantial patient value in almost 80% of our cases. Patient pre-operative pain/function, tobacco use, and type of procedure (anatomic or reverse) are important factors associated with patient value after TSA. A VBHC community gathering all the different key players is definitely needed to establish solid guidelines and improve our practice according to experiences of each.

**Author Contributions:** Conceptualization, A.L. and H.B.; methodology, A.L. and H.B.; investigation, A.L. and H.B.; data curation, A.L. and H.B.; writing—original draft preparation, A.L. and H.B.; writing—review and editing, A.L., R.E., A.A., M.B. and H.B.; supervision, A.L. and H.B. All authors have read and agreed to the published version of the manuscript.

**Funding:** This research was founded by a gran<sup>t</sup> from FORE (Foundation for Research and Teaching in Orthopaedics, Sports Medicine, Trauma and Imaging in the Musculoskeletal System): gran<sup>t</sup> number 2021-56.

**Institutional Review Board Statement:** The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Ethics Committee (Commission cantonale d'éthique de la recherche (CCER) de Genève: Shoulder Outcomes Clinical Study, n◦ 2014-277).

**Informed Consent Statement:** Informed consent was obtained from all subjects involved in the study.

**Data Availability Statement:** Details regarding where data supporting reported results can be requested at the following e-mail address: hugo.bothorel@latour.ch.

**Acknowledgments:** The authors are grateful towards Yonas Abraham for the managemen<sup>t</sup> accounting analyses, and towards Florian Rossiaud-Fischer and Ezra Bottequin for their help in manuscript editing.

**Conflicts of Interest:** Lädermann reports that he is a paid consultant for Arthrex, Inc., Stryker and Medacta and receives royalties from Stryker. He is the founder of FORE foundation, Med4cast, and of BeeMed. Eurin, Alibert, Bensouda, and Bothorel declare no conflict of interest that could influence the representation or interpretation of reported research results.
